This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Cancer Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Inhoo Kim: Innovator in Oncolytic Virus Research
Introduction
Inhoo Kim is a prominent inventor based in Goyang, South Korea. He has made significant contributions to the field of oncolytic virus research, focusing on enhancing the efficacy of viral therapies for cancer treatment. His innovative work has the potential to improve patient outcomes in oncology.
Latest Patents
Inhoo Kim holds a patent for a composition comprising NC886 aimed at improving oncolytic virus activity or production. The present invention relates to a composition for enhancing oncolytic virus activity which comprises NC886, and a composition for enhancing virus production which comprises the same. This patent highlights his commitment to advancing cancer treatment methodologies.
Career Highlights
Inhoo Kim is affiliated with the National Cancer Center, where he conducts research and develops innovative solutions for cancer therapies. His work at this esteemed institution underscores his dedication to improving cancer treatment options through scientific research and innovation.
Collaborations
In his professional journey, Inhoo Kim has collaborated with notable colleagues, including Sangjin Lee and Seungpil Shin. These collaborations have likely contributed to the advancement of his research and the development of impactful innovations in the field.
Conclusion
Inhoo Kim's contributions to oncolytic virus research exemplify the importance of innovation in the fight against cancer. His patent and work at the National Cancer Center reflect a commitment to enhancing therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
